跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CIP ABIRATERONE abiraterone acetate 250 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
CIP ABIRATERONE abiraterone acetate 250 mg tablet bottle
Approved
STANDARD
CIP ABIRATERONE abiraterone acetate 250 mg tablet bottle
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
60daf014b6bcc19e
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
60daf014b6bcc19e
Product Name
CIP ABIRATERONE abiraterone acetate 250 mg tablet bottle
Artg Id
443940
Artg Name
CIP ABIRATERONE abiraterone acetate 250 mg tablet bottle
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2025-07-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
60daf014b6bcc19e
Type
Standard
Back to TGA Approvals
